Protecting Your Retina Health for Lifelong Vision

Age is the single largest risk factor for many retinal diseases. Adults over 50 face a significantly higher risk of age-related macular degeneration and other degenerative retinal conditions, and that risk continues to increase with each passing decade.

Family history also plays an important role. If a parent or sibling has had AMD, diabetic retinopathy, or retinal detachment, your own risk may be elevated. Sharing your family eye health history with a retina specialist helps determine how closely and how frequently you should be monitored.

Diabetes is one of the most significant contributors to retinal disease. According to the American Society of Retina Specialists, approximately 45 percent of people with diabetes develop some degree of diabetic retinopathy, a condition in which high blood sugar gradually damages the small blood vessels inside the retina, causing them to leak, swell, or grow abnormally.

Both type 1 and type 2 diabetes increase this risk. The longer a person has lived with diabetes, the greater the chance of developing retinal changes. Maintaining tight blood sugar control is one of the most effective strategies for reducing this risk and slowing the progression of existing disease.

Several risk factors for retinal disease are modifiable, meaning you have real ability to reduce them through consistent daily choices.

• Smoking significantly raises the risk of AMD and damages blood vessels throughout the body, including those in the retina.
• Obesity increases the risk of both diabetes and AMD.
• Prolonged sun exposure without UV-protective eyewear can contribute to cumulative retinal damage over time.
• A diet low in antioxidants, leafy greens, and omega-3 fatty acids may increase vulnerability to macular disease.

No single change eliminates retinal risk entirely, but a consistent combination of healthy habits meaningfully reduces it over time.

Uncontrolled high blood pressure places constant strain on the small, fragile blood vessels inside the retina. Over time, this can cause hypertensive retinopathy, a condition in which retinal vessels become narrowed, damaged, or prone to bleeding. Elevated cholesterol can also affect blood flow to and within the retina.

Managing both conditions through medication, diet, and regular monitoring is an important part of protecting your eye health alongside your overall cardiovascular health.

Anti-VEGF medications block a protein called vascular endothelial growth factor (VEGF), which drives the growth of abnormal, leaking blood vessels inside the eye. These injections are a primary treatment for wet AMD, a form of age-related macular degeneration involving abnormal vessel growth beneath the retina, and for diabetic macular edema (DME), which is swelling in the center of the retina caused by diabetes-related vessel damage.

Commonly used anti-VEGF agents include aflibercept, ranibizumab, faricimab, and bevacizumab. Your retina specialist will determine which medication and injection schedule are most appropriate based on your diagnosis and how your eye responds over time. Injections are administered in our office at intervals tailored to your individual treatment plan.

Geographic atrophy is an advanced form of dry AMD in which retinal cells in the macula gradually break down and die, creating areas of permanent vision loss. It is a distinct condition from wet AMD and requires different treatment. Two complement inhibitor medications, pegcetacoplan and avacincaptad pegol, have been FDA-approved specifically to slow the growth of geographic atrophy lesions. Both are given as intravitreal injections, meaning they are delivered directly into the eye.

These treatments slow the rate of progression but do not restore vision that has already been lost. Your retina specialist will evaluate whether treatment is appropriate based on your stage of disease, overall eye health, and individual circumstances.

Laser photocoagulation uses a precisely targeted thermal laser to seal leaking blood vessels or create a barrier that helps prevent a retinal detachment from spreading. Photodynamic therapy (PDT) uses a light-activated medication to treat certain abnormal blood vessel conditions in the retina.

For retinal detachment, surgical options may include vitrectomy (removal of the vitreous gel to allow retinal repair), scleral buckle (a flexible silicone band placed around the outside of the eye to provide structural support), pneumatic retinopexy (injection of a gas bubble to press the retina back into its proper position), and cryoretinopexy (a freezing treatment used to seal retinal tears). The appropriate approach depends on the type, location, and severity of the detachment.

Gene therapy is a promising and active area of retinal research. One FDA-approved gene therapy is currently available for a specific inherited retinal dystrophy caused by mutations in the RPE65 gene. Ongoing clinical trials continue to explore new approaches for geographic atrophy, inherited retinal diseases, and other conditions where current treatment options remain limited.

Our practice maintains active involvement in clinical research, which may give eligible patients access to investigational treatments under careful physician supervision. If you would like to know whether any current studies may be relevant to your diagnosis, please ask our team during your evaluation.

While retinal diseases become more common after age 50, certain groups benefit from starting earlier. People with diabetes, a strong family history of retinal disease, or high myopia (severe nearsightedness) may need retinal monitoring well before age 50. A baseline dilated eye exam by age 40 is a practical starting point for most adults, since it helps identify risk factors before disease develops. From there, your provider can build a personalized screening schedule based on your individual findings.

In most cases, retinal cells that have been damaged or lost do not naturally regrow or repair themselves, which is why prevention and early detection matter so much. Modern treatments such as anti-VEGF injections can slow or halt disease progression, and some patients experience partial vision improvement, but the primary goal of treatment is almost always to protect the vision that remains. Emerging therapies, including gene therapy, may eventually expand what is possible for certain inherited and degenerative conditions, though research is still ongoing.

AREDS2 supplements are specifically indicated for people who already have intermediate AMD or advanced AMD in one eye, not as a general preventive tool for people with healthy eyes. No supplement has been shown to prevent retinal disease from developing in people who do not yet have it. If you are unsure whether these supplements apply to your situation, your retina specialist can review your current eye health and give you a direct answer. For most people without AMD, a nutrient-rich diet remains the most evidence-based approach to supporting eye health through nutrition.

For most people with retinal conditions, moderate physical activity is not only safe but actively beneficial, since regular exercise supports blood pressure control, blood sugar management, and healthy body weight, all of which directly affect retinal health. That said, specific restrictions may apply depending on your condition and treatment history. Following retinal detachment repair, for example, certain activities may need to be temporarily limited while the eye heals. Always discuss exercise plans with your retina specialist before significantly changing your activity level if you have an active retinal condition.

Anti-VEGF injections are performed in our office, not in a hospital or surgical center. The eye is numbed with anesthetic drops or a small injection of local anesthesia so the procedure itself is generally not painful. A very fine needle delivers the medication into the vitreous, the clear gel-like substance that fills the interior of the eye. The entire process takes only a few minutes. Most patients notice mild pressure, temporary redness, or a gritty sensation afterward, which typically resolves within a day or two. Your doctor will always discuss potential risks with you before the procedure.

You do not need a referral to schedule an appointment with our team. While many patients come to us through a referral from their general eye doctor or optometrist, we also welcome patients who contact us directly. If you are experiencing urgent symptoms such as sudden vision loss, a significant increase in floaters, flashes of light, or a shadow across your vision, please reach out as soon as possible rather than waiting for a referral to be processed. Time matters for many retinal conditions, and we are prepared to see urgent cases promptly.